First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure – impact on diastolic function

Hashmat S. Z. Bahrami; Rasmus Bo Hasselbalch; Helle  Søholm; Jakob Hartvig Thomsen; Mathias Sørgaard; Klaus Fuglsang Kofoed; Nana Valeur; Søren Boesgaard; Natasha Alexandria Sarah  Fry; Jacob Eifer Møller; Anna Axelsson; Lars  Kober; Kasper Karmark Iversen; Helge Rasmussen; Henning Bundgaard

doi:10.1093/eurheartj/ehac544.955

First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure – impact on diastolic function

Hashmat S. Z. Bahrami^*, Rasmus Bo Hasselbalch, Helle Søholm, Jakob Hartvig Thomsen, Mathias Sørgaard, Klaus Fuglsang Kofoed, Nana Valeur, Søren Boesgaard, Natasha Alexandria Sarah Fry, Jacob Eifer Møller, Anna Axelsson, Lars Kober, Kasper Karmark Iversen, Helge Rasmussen, Henning Bundgaard

^*Corresponding author af dette arbejde

Originalsprog	Engelsk
Artikelnummer	955
Tidsskrift	European Heart Journal
Antal sider	1
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehac544.955
Status	Udgivet - 3 okt. 2022

Adgang til dokumentet

10.1093/eurheartj/ehac544.955

Citationsformater

Bahrami, H. S. Z., Hasselbalch, R. B., Søholm, H., Thomsen, J. H., Sørgaard, M., Kofoed, K. F., Valeur, N., Boesgaard, S., Fry, N. A. S., Møller, J. E., Axelsson, A., Kober, L., Iversen, K. K., Rasmussen, H., & Bundgaard, H. (2022). First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure – impact on diastolic function. European Heart Journal, Artikel 955. https://doi.org/10.1093/eurheartj/ehac544.955

Bahrami, HSZ, Hasselbalch, RB, Søholm, H, Thomsen, JH , Sørgaard, M , Kofoed, KF, Valeur, N, Boesgaard, S, Fry, NAS, Møller, JE , Axelsson, A , Kober, L , Iversen, KK, Rasmussen, H & Bundgaard, H 2022, 'First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure – impact on diastolic function', European Heart Journal. https://doi.org/10.1093/eurheartj/ehac544.955

@article{c04562a9de924987b46596682551b53c,

title = "First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure – impact on diastolic function",

author = "Bahrami, {Hashmat S. Z.} and Hasselbalch, {Rasmus Bo} and Helle S{\o}holm and Thomsen, {Jakob Hartvig} and Mathias S{\o}rgaard and Kofoed, {Klaus Fuglsang} and Nana Valeur and S{\o}ren Boesgaard and Fry, {Natasha Alexandria Sarah} and M{\o}ller, {Jacob Eifer} and Anna Axelsson and Lars Kober and Iversen, {Kasper Karmark} and Helge Rasmussen and Henning Bundgaard",

year = "2022",

month = oct,

day = "3",

doi = "10.1093/eurheartj/ehac544.955",

language = "English",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

}

TY - ABST

T1 - First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure – impact on diastolic function

AU - Bahrami, Hashmat S. Z.

AU - Hasselbalch, Rasmus Bo

AU - Søholm, Helle

AU - Thomsen, Jakob Hartvig

AU - Sørgaard, Mathias

AU - Kofoed, Klaus Fuglsang

AU - Valeur, Nana

AU - Boesgaard, Søren

AU - Fry, Natasha Alexandria Sarah

AU - Møller, Jacob Eifer

AU - Axelsson, Anna

AU - Kober, Lars

AU - Iversen, Kasper Karmark

AU - Rasmussen, Helge

AU - Bundgaard, Henning

PY - 2022/10/3

Y1 - 2022/10/3

U2 - 10.1093/eurheartj/ehac544.955

DO - 10.1093/eurheartj/ehac544.955

M3 - Conference abstract in journal

SN - 0195-668X

JO - European Heart Journal

JF - European Heart Journal

M1 - 955

ER -